icon-folder.gif   Conference Reports for NATAP  
 
  EASL 47th Annual Meeting
April 18th - 22nd 2012
Barcelona, Spain
Back grey_arrow_rt.gif
 
 
 
Persistence of NS5A Drug Resistance Mutations Following 3 Days of GS-5885 Monotherapy in Genotype-1 HCV Patients is Dependent on the HCV Subtype and Specific Mutation
 
 
  Reported by Jules Levin
EASL 2012 Apr 18-22 Barcelona Spain
 
KA Wong1, A Worth1, DM Brainard1, E Lawitz2, MD Miller1, H Mo1 1Gilead Sciences, Inc., Foster City, CA, USA, 2Alamo Medical Research, San Antonio, TX, USA

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif

EASL9.gif

EASL10.gif